CFTR and cystic fibrosis: Strubberg et al. noted that inhibition of proliferation of ISC in patients with cystic fibrosis (CF) by cystic fibrosis transmembrane conductance regulator (Cftr) may promote Wnt/β-catenin signaling, thereby increasing the risk of gut neoplasia 150.